Cargando…
Risk factors and effective management of preeclampsia
Preeclampsia, a hypertensive disorder of pregnancy is estimated to complicate 2%–8% of pregnancies and remains a principal cause of maternal and fetal morbidity and mortality. Preeclampsia may present at any gestation but is more commonly encountered in the third trimester. Multiple risk factors hav...
Autores principales: | English, Fred A, Kenny, Louise C, McCarthy, Fergus P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354613/ https://www.ncbi.nlm.nih.gov/pubmed/25767405 http://dx.doi.org/10.2147/IBPC.S50641 |
Ejemplares similares
-
Activation of a TLR9 mediated innate immune response in preeclampsia
por: Williamson, Rachel D., et al.
Publicado: (2019) -
Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study
por: Khashan, Ali S., et al.
Publicado: (2019) -
Correction: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study
por: Khashan, Ali S., et al.
Publicado: (2019) -
Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia
por: McCarthy, Cathal, et al.
Publicado: (2016) -
Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test
por: Kenny, Louise C., et al.
Publicado: (2020)